Toxicology of Industrial Compounds

B.G.LAKE AND R.J.PRICE 233
FOXWORTHY, P.S. and EACHO, P.I., 1994, Cultured hepatocytes for studies of
peroxisome proliferation: methods and applications, Journal of
Pharmacological and Toxicological Methods, 31, 21–30.
GIBSON, G.G., 1989, Comparative aspects of the mammalian cytochrome P450IV
gene family, Xenobiotica, 19, 1123–48.
GOEL, S.K., LALWANI, N.D., FAHL, W.E. and REDDY, J.K., 1985, Lack of
covalent binding of peroxisome proliferators nafenopin and WY-14,643 to
DNA in vivo and in vitro, Toxicology Letters, 24, 37–43.
GRAHAM, M.J., WILSON, S.A., WINHAM, M.A., SPENCER, A.J., REES, J.A.,
OLD, S.L. and BONNER, F.W., 1994, Lack of peroxisome proliferation in
marmoset liver following treatment with ciprofibrate for 3 years, Fundamental
and Applied Toxicology, 22, 58–64.
GRASL-KRAUPP, B., HUBER, W. and SCHULTE-HERMANN, R., 1993, Are
peroxisome proliferators tumour promoters in rat liver? in Gibson, G. and
Lake, B. (Eds) Peroxisomes: Biology and Importance in Toxicology and
Medicine, pp. 667–93, London: Taylor and Francis.
GRAY, T.J.B., BEAMAND, J.A., LAKE, B.G., FOSTER, J.R. and GANGOLLI, S.D.,
1982, Peroxisome proliferation in cultured rat hepatocytes produced by
clofibrate and phthalate ester metabolites, Toxicology Letters, 10, 273–9.
GUPTA, R.C., GOEL, S.K., EARLEY, K., SINGH, B. and REDDY, J.K., 1985, 32 P-
Postlabelling analysis of peroxisome proliferator-DNA adduct formation in rat
liver in vivo and hepatocytes in vitro, Carcinogenesis, 6, 933–6.
HANEFELD, M., KEMMER, C. and KADNER, E., 1983, Relationship between
morphological changes and lipid-lowering action of pchlorophenoxyisobutyric
acid (CPIB) on hepatic mitochondria and
peroxisomes in man, Atherosclerosis, 46, 239–46.
HARTIG, F., STEGMEIER, K., HEBOLD, G.,ÖZEL, M. and FAHIMI, H.D.,
1982, Study of liver enzymes: peroxisome proliferation and tumor rates in rats
at the end of carcinogenicity studies with bezafibrate and clofibrate, Annals of
the New York Academy of Science, 386, 464–7.
HAWKINS, J.M., JONES, W.E., BONNER, F.W. and GIBSON, G.G., 1987, The
effect of peroxisome proliferators on microsomal, peroxisomal and
mitochondrial enzyme activities in the liver and kidney, Drug Metabolism
Reviews, 18, 441–515.
HESS, R., STÄUBLI, W. and REISS, W., 1965, Nature of the hepatomegalic effect
produced by ethyl chlorophenoxyisobutyrate in the rat, Nature, 208, 856–8.
HINTON, R.H. and PRICE, S.C., 1993, Extrahepatic peroxisome proliferation and
the extrahepatic effects of peroxisome proliferators, in Gibson, G. and Lake,
B. (Eds) Peroxisomes: Biology and Importance in Toxicology and Medicine,
pp. 487– 511, London: Taylor and Francis.
HWANG, J.-J., HSAI, M.T.S. and JIRTLE, R.L., 1993, Induction of sister
chromatid exchange and micronuclei in primary cultures of rat and human
hepatocytes by the peroxisome proliferator Wy-14,643, Mutation Research,
286, 123–33.
ISHII, H., FUKUMORI, N., HORIE, S. and SUGA, T., 1980, Eifects of fat content
in the diet on hepatic peroxisomes of the rat, Biochimica et Biophysica Acta,
617, 1–11.